Cholecystokinin protects mouse liver against ischemia and reperfusion injury

Ying Zhang(Second Military Medical University), Xiaoming Deng(Second Military Medical University), Long Guo(Second Affiliated Hospital of Xi'an Jiaotong University), Han Shao(Xuzhou University of Technology), Jiali Zhu(Jiangsu Province Hospital), Jinbao Li(Qilu University of Technology), Yun Zou(University of Liège), Fang Wang(Zunyi Medical University)
International Immunopharmacology
May 16, 2017
10.1016/j.intimp.2017.03.028
Cited by 26

Related Papers

Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
|Critical Care|2010|307
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
|Critical Care|2011|254
Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis
|Blood|2021|218
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
|Critical Care|2011|215